ARQT vs. SHOP
ARQT (Arcutis Biotherapeutics, Inc.) and SHOP (Shopify Inc.) are both stocks. ARQT operates in Biotechnology (Healthcare), while SHOP operates in Software - Application (Technology). Over the past 5 years, ARQT returned -3.61%/yr vs -0.76%/yr for SHOP. At a 0.26 correlation, their price movements are largely independent.
Performance
ARQT vs. SHOP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARQT achieves a -24.41% return, which is significantly higher than SHOP's -27.91% return.
ARQT
- 1D
- 2.81%
- 1M
- -6.28%
- YTD
- -24.41%
- 6M
- -29.56%
- 1Y
- 65.41%
- 3Y*
- 36.87%
- 5Y*
- -3.61%
- 10Y*
- —
SHOP
- 1D
- 2.74%
- 1M
- 7.81%
- YTD
- -27.91%
- 6M
- -28.51%
- 1Y
- 12.03%
- 3Y*
- 24.65%
- 5Y*
- -0.76%
- 10Y*
- 44.13%
ARQT vs. SHOP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
ARQT Arcutis Biotherapeutics, Inc. | -24.41% | 108.47% | 331.27% | -78.18% | -28.64% | -26.27% | 29.04% |
SHOP Shopify Inc. | -27.91% | 51.39% | 36.50% | 124.43% | -74.80% | 21.68% | 143.09% |
Correlation
The correlation between ARQT and SHOP is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2020 | 0.26 |
Fundamentals
ARQT:
$2.84B
SHOP:
$151.24B
ARQT:
-$0.02
SHOP:
$1.02
ARQT:
6.93
SHOP:
16.50
ARQT:
14.97
SHOP:
12.10
ARQT:
$415.62M
SHOP:
$9.20B
ARQT:
$377.98M
SHOP:
$5.93B
ARQT:
$12.21M
SHOP:
$1.60B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARQT vs. SHOP — Risk / Return Rank
ARQT
SHOP
ARQT vs. SHOP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Arcutis Biotherapeutics, Inc. (ARQT) and Shopify Inc. (SHOP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ARQT | SHOP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.93 | ||
| Sortino ratioReturn per unit of downside risk | +1.23 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.09 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 1.75 | 0.26 | +1.49 |
| Martin ratioReturn relative to average drawdown | 4.16 | 0.56 | +3.60 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ARQT | SHOP | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.14 | 0.21 | +0.93 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | -0.01 | -0.04 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.75 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.00 | 0.70 | -0.70 |
Drawdowns
ARQT vs. SHOP - Drawdown Comparison
The maximum ARQT drawdown since its inception was -95.02%, which is greater than SHOP's maximum drawdown of -84.82%. Use the drawdown chart below to compare losses from any high point for ARQT and SHOP.
Loading charts...
Drawdown Indicators
| ARQT | SHOP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.02% | -84.82% | -10.20% |
Max Drawdown (1Y)Largest decline over 1 year | -37.50% | -46.71% | +9.21% |
Max Drawdown (3Y)Largest decline over 3 years | -83.24% | -46.71% | -36.53% |
Max Drawdown (5Y)Largest decline over 5 years | -93.67% | -84.82% | -8.85% |
Max Drawdown (10Y)Largest decline over 10 years | — | -84.82% | — |
Current DrawdownCurrent decline from peak | -40.64% | -35.18% | -5.46% |
Average DrawdownAverage peak-to-trough decline | -50.15% | -28.21% | -21.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.76% | 21.47% | -5.71% |
Volatility
ARQT vs. SHOP - Volatility Comparison
Arcutis Biotherapeutics, Inc. (ARQT) has a higher volatility of 20.40% compared to Shopify Inc. (SHOP) at 17.89%. This indicates that ARQT's price experiences larger fluctuations and is considered to be riskier than SHOP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARQT | SHOP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.40% | 17.89% | +2.51% |
Volatility (6M)Calculated over the trailing 6-month period | 36.80% | 43.39% | -6.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 57.61% | 57.22% | +0.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 71.79% | 65.52% | +6.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 76.97% | 59.05% | +17.92% |
Dividends
ARQT vs. SHOP - Dividend Comparison
Neither ARQT nor SHOP has paid dividends to shareholders.
Financials
ARQT vs. SHOP - Financials Comparison
This section allows you to compare key financial metrics between Arcutis Biotherapeutics, Inc. and Shopify Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ARQT and SHOP have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARQT has higher volatility (20.40%) compared to SHOP (17.89%). In terms of maximum drawdown, ARQT dropped -95.02% vs SHOP's -84.82%.
ARQT currently has the higher Sharpe Ratio (1.14 vs 0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARQT and SHOP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer